Migraine is a neurological disorder with intense headaches and various symptoms, which affects the quality of life of millions of people. Medication overuse headache (MOH) is a debilitating condition caused by excessive use of pain relievers, often to manage chronic headaches. Pharmacists play a crucial role in the management of both conditions by advising patients about proper medication usage, suggesting non-pharmacological interventions and lifestyle changes, and collaborating with other healthcare professionals to ensure patients receive appropriate care. This event will explore different options for the management of migraine and MOH and provide guidance on how pharmacists may support patients.

Moderator:
- Tara Hehir, SAPS President Social and Administrative Pharmacy Section - Australia

Panellists:
- Jacinta Johnson, Senior Lecturer in Pharmacy University of South Australia - Australia
- Pernilla Bjerkeli, Associate Professor in Public Health and Pharmacist University of Skövde / School of Health Sciences - Sweden

As mental health problems become more prevalent, this event will address the role that pharmacists can play in integrated interprofessional care, through early screening, effective referral and support of people with mental health conditions. Attendees will gain insight into the latest screening tools that enable pharmacists to identify individuals at risk and refer them to appropriate resources. In addition, the event will explore the pharmacist's role in providing appropriate support and counseling to patients and working with healthcare teams to promote holistic mental wellness. Through this event, FIP hopes to empower pharmacists to transform mental health care.

Moderator:
- Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation - Sweden

Panellists:
- Claire O'Reilly, Associate Professor, Sydney Pharmacy School The University of Sydney - Australia
- Hayley Gorton, Senior Lecturer In Pharmacy Practice University of Huddersfield - UK
- Sheilla; Ferreira, PhD Sheilla Ferreira Department of Pharmacy, Federal University of Ceará, Brazil - Brazil

The academic section concluded with a strategic plan, and advocacy and global influence were identified as critical priorities for the section. Panelists representing key stakeholders in Asia (as part of a worldwide series) will be invited to address the following questions related to advocacy and change management.

Moderator:
- Toyin Tofade, President Albany College of Pharmacy and Health Sciences - United States

Panellists:
- Yolanda Robles, President - Professor; BS Pharm, MPharm, PhD
Federation of Asian Pharmaceutical Association - Philippines
- Emer Ken-ichi Inui, President - Professor Asian Association of Schools of Pharmacy - Kyoto University - Japan
- TV Narayana, President - Owner Indian Pharmaceutical Association - SBD College of Pharmacy - India
- Amrahi Buang, President Malaysian Pharmacists Society - Malaysia

Common ailment schemes (CAS) (aka minor ailment schemes) are programmes where patients can receive advice, care and, when needed, treatment for an agreed range of common, self-limiting health problems, generally without the need for appointment. They are equally important for triaging patients that do require being seen by a medical doctor or nurse. Such schemes greatly contribute to providing accessible, agile and quality care to patients, and to reducing pressure on general practice and emergency departments, thus making health systems more efficient. FIP conducted a global study on common ailments schemes, including a literature review, a survey of its member organisations, a compilation of case studies and an insight board meeting. The outcomes have been put together into a global intelligence report that will be presented and discussed at this event.

Medication management is particularly important for people living with cardiovascular diseases (CVD) due to the increased likelihood of co-morbidities. This often leads to the need for multiple pharmacological therapies, resulting in polypharmacy. Close medication management between pharmacists and CVD patients is essential to ensure effective achievement of treatment goals, ensure adherence and reduce the incidence of unpleasant or fatal side effects, thereby reducing the burden of CVD. This digital event will address the importance of proper medication management and adherence in the successful management of CVD, the factors associated with non-adherence to CVD medications, and the economic impact of pharmacist interventions on CVD medication adherence.

Millions of people across the globe live with pain on a daily basis, including from osteoarthritis, rheumatoid arthritis, other forms of musculoskeletal pain and other types of pain. Pharmacists are uniquely positioned to support patients in achieving appropriate pain management and control, by providing advice on pharmacological, non-pharmacological and behavioural measures. By enhancing their knowledge, pharmacists can meaningfully contribute to the interdisciplinary care of pain patients. This event will explore evidence-based approaches that pharmacists can recommend for improving the quality of life of those living with pain.